List of Salesforce Agentforce for Life Sciences Customers
San Francisco, 94105, CA,
United States
Since 2010, our global team of researchers has been studying Salesforce Agentforce for Life Sciences customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Salesforce Agentforce for Life Sciences for Chatbots and Conversational AI from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Salesforce Agentforce for Life Sciences for Chatbots and Conversational AI include: AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Astrazeneca, a United Kingdom based Life Sciences organisation with 70600 employees and revenues of $54.07 billion, Novartis, a Switzerland based Life Sciences organisation with 75883 employees and revenues of $51.72 billion, Haleon, a United Kingdom based Consumer Packaged Goods organisation with 24561 employees and revenues of $14.86 billion and many others.
Contact us if you need a completed and verified list of companies using Salesforce Agentforce for Life Sciences, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Salesforce Agentforce for Life Sciences customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | Salesforce | Salesforce Agentforce for Life Sciences | Chatbots and Conversational AI | 2025 | n/a |
In 2025 AstraZeneca selected Salesforce Agentforce for Life Sciences to transform customer engagement globally. Salesforce Agentforce for Life Sciences is being deployed under the Chatbots and Conversational AI category to foster stronger relationships with healthcare professionals through data driven, AI powered engagement across oncology, rare diseases, biopharmaceuticals, cardiovascular, renal and metabolism, and respiratory and immunology.
The implementation centers on conversational assistants and agent assist capabilities, conversation orchestration, knowledge management for approved medical content, and embedded analytics to surface engagement signals to field teams. Configurations emphasize lifecycle workflows for HCP interactions, consent and opt out handling, and controlled content authoring for regulated communications. Core Chatbots and Conversational AI functional elements such as intent recognition, context management, and escalation to human agents are central to the solution design.
Deployment is built on Salesforce platform services and is intended to operate across AstraZeneca commercial and medical affairs functions globally. The technical architecture focuses on cloud hosted conversational services with orchestration into CRM workflows and field engagement processes, aligning conversational channels with enterprise engagement records and approved content stores to maintain consistency across HCP touchpoints. Integrations concentrate on channel unification and synchronizing interaction records with enterprise engagement workflows.
Governance arrangements prioritize regulatory compliance, data governance, and AI oversight specific to life sciences communications, with process controls for content approval and audit trails for HCP interactions. Rollout is framed as a staged global customer engagement program supporting targeted therapeutic areas, with clinical and commercial governance gates for each phase. The program is positioned to transform customer engagement through data driven, AI powered interactions rather than specific operational metrics.
|
|
|
Astrazeneca | Life Sciences | 70600 | $54.1B | United Kingdom | Salesforce | Salesforce Agentforce for Life Sciences | Chatbots and Conversational AI | 2025 | n/a |
In 2025 AstraZeneca implemented Salesforce Agentforce for Life Sciences to transform global HCP and commercial engagement, deploying a Chatbots and Conversational AI capability to drive personalized, AI-driven interactions. The CRM and commercial implementation is headquartered in the United Kingdom and is explicitly aimed at consolidating medical and commercial coordination across global HCP touchpoints.
The deployment is described as leveraging Salesforce Agentforce for Life Sciences with module usage inferred to include Agentforce 360, Life Sciences Cloud, and Data Cloud, supporting conversational agent workflows, contextual routing, and AI personalization. Configuration emphasis is placed on agent orchestration, conversational session management, and HCP profile enrichment to enable targeted, consistent communications across commercial and medical workflows.
Operational coverage centers on global HCP engagement and commercial teams, with the implementation positioned within AstraZeneca's Salesforce commercial stack and expected to use Salesforce Data Cloud to harmonize HCP signals and interaction histories. The initiative touches commercial, medical affairs, and field engagement functions, aligning conversational AI outputs with CRM records and outreach orchestration.
Governance focuses on consolidating medical-commercial coordination and establishing orchestration rules for AI-driven interactions to ensure compliant, consistent engagement patterns. Expected outcomes stated by the customer include improved personalized HCP experiences and stronger orchestration between medical and commercial stakeholders.
|
|
|
Haleon | Consumer Packaged Goods | 24561 | $14.9B | United Kingdom | Salesforce | Salesforce Agentforce for Life Sciences | Chatbots and Conversational AI | 2025 | n/a |
In 2025 Haleon implemented Salesforce Agentforce for Life Sciences as part of a coordinated Salesforce Life Sciences Cloud and Data Cloud initiative to support its commercial customer engagement capability. The implementation is explicitly positioned as a consumer health CRM deployment based in the United Kingdom, supporting a 4,500-strong sales force and targeting improved engagement with pharmacists and healthcare professionals worldwide.
The deployment centers on Salesforce Life Sciences Cloud, Salesforce Data Cloud, and Salesforce Agentforce for Life Sciences, with configuration focused on customer engagement workflows, consolidated HCP and pharmacy profiles, and conversational AI-driven assistance for field reps. Functional capabilities implemented include conversational agents for rep-facing interactions, guided engagement workflows and scripting, knowledge access for product and clinical information, and automated activity capture to maintain CRM records within the Life Sciences Cloud.
Architecturally the solution links Data Cloud customer and identity objects to Life Sciences Cloud records to create unified HCP and pharmacy profiles, while Agentforce provides Chatbots and Conversational AI functionality embedded in the sales rep workspace. Integration points are centered on data synchronization between Data Cloud and Life Sciences Cloud for real-time profile enrichment and engagement context, supporting field call planning and follow-up activity in the commercial CRM.
Commercial governance emphasizes standardized engagement workflows, documented compliance controls for healthcare professional interactions, and role-based access within the Life Sciences Cloud and Agentforce interfaces. Rollout and operational scope cover the global sales organization with UK-based program management, and the initiative is framed to support rep productivity and deeper pharmacist and HCP engagement rather than to report specific outcome metrics.
|
|
|
|
Life Sciences | 75883 | $51.7B | Switzerland | Salesforce | Salesforce Agentforce for Life Sciences | Chatbots and Conversational AI | 2025 | n/a |
|
Buyer Intent: Companies Evaluating Salesforce Agentforce for Life Sciences
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||